In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...

Only adults 65 and older or people with another health problem that puts them at higher risk will be able to get the shots ...

The 2025 "American Idol" champion stops by "GMA" to perform his new single, “Heal,” and reflect on his path to victory. A new Trump administration vaccine policy will limit access to COVID-19 shots.

The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...

Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's ...

COVID-19 shots for healthy younger adults and children will no longer be routinely approved under a major new policy shift unveiled Tuesday by the Trump administration.

The U.S. Food and Drug Administration plans to require new clinical trials for approval of annual COVID-19 boosters for ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine, but with unusual ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization ...